SEARCH

SEARCH BY CITATION

References

  • 1
    Hunt SA. Taking heart–cardiac transplantation past, present, and future. N Engl J Med 2006; 355: 231235.
  • 2
    Taylor D, Edwards L, Boucek M et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-third official adult heart transplantation report–2006. J Heart Lung Transplant 2006; 25: 869879.
  • 3
    Almenar Bonet L. Registro Español de Trasplante Cardiaco.XVII Informe Oficial de la Sección de Insuficiencia cardiaca, trasplante cardiaco y otras alternativas terapéuticas de la Sociedad Española de Cardiología (1984–2005). Rev Esp Cardiol 2006; 59: 12831291.
  • 4
    Hunt S. Malignancy in organ transplantation: Heart. Transpl Proc 2002; 34: 18741876.
  • 5
    Hauptman PJ, Mehra MR. It is time to stop ignoring malignancy in heart transplantation: A call to arms. J Heart Lung Transplant 2005; 24: 11111113.
  • 6
    Penn I. Post-transplant malignancy: The role of immunosuppression. Drug Saf 2000; 23: 101113.
  • 7
    Dantal J, Soulillou J. Immunosuppressive drugs and the risk of cancer after organ transplantation. N Engl J Med 2005; 352: 13711373.
  • 8
    O'Neill JO, Edwards LB, Taylor DO. Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: Analysis of the transplant registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006; 25: 11861191.
  • 9
    Opelz G, Dohler B. Lymphomas after solid organ transplantation: A collaborative transplant study report. Am J Transplant 2003; 4: 222230.
  • 10
    Roithmaier S, Haydon AM, Loi S et al. Incidence of malignancies in heart and/or lung transplant recipients: A single-institution experience. J Heart Lung Transplant 2007; 26: 8459.
  • 11
    Gao SZ, Chaparro SV, Perlroth M et al. Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University. J Heart Lung Transplant 2003; 22: 505514.
  • 12
    El-Hamamsy I, Stevens LM, Carrier M et al. Incidence and prognosis of cancer following heart transplantation using RATG induction therapy. Transpl Int 2005; 18: 12801285.
  • 13
    Penn I. Incidence and treatment of neoplasia after transplantation. J Heart Lung Transplant 1993; 12(6 Pt 2): S328S336.
  • 14
    Witherow BA, Roth GS, Carrozza MA et al. The Israel Penn International Transplant Tumor Registry. AMIA Annu Symp Proc 2003: 1053.
  • 15
    Swinnen L, Costanzo-Nordin M, Fisher S et al. Increased incidence of lymphoproliferative disorder after inmunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients. N Engl J Med 1990; 323: 17231728.
  • 16
    Ratkovec R, O'Connell J, Bristow M et al. Post-transplant lymphoproliferative disease in cardiac transplant patients receiving OKT3 therapy. Clin Transplantation 1992;(Spec issue): 260264.
  • 17
    Peraira JR, Segovia J, Fuertes B et al. Current induction immunosuppression and post-heart transplant lymphoproliferative disorders. Transplant Proc 2003; 35: 20092010.
  • 18
    Hodson EM, Jones CA, Webster AC et al. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: A systematic review of randomised controlled trials. Lancet 2005; 365: 21052115.
  • 19
    Funch DP, Walker AM, Schneider G, Ziyadeh NJ, Pescovitz MD. Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients. Am J Transplant 2005; 5: 28942900.
  • 20
    Valantine H. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology. J Heart Lung Transplant 2007; 26: 557564.
  • 21
    Crespo-Leiro MG, Alonso-Pulpon L, Arizon JM et al. Influence of induction therapy, immunosuppressive regimen and anti-viral prophylaxis on development of lymphomas after heart transplantation: Data from the Spanish Post-Heart Transplant Tumour Registry. J Heart Lung Transplant 2007; 26: 11051109.